Skip to main content
. 2020 Mar 24;14:245. doi: 10.3389/fnins.2020.00245

TABLE 2.

Severity of SAH and mortality.

Groups Excluded Mortality
Experiment 1
Sham 0 0%(0/12)
SAH (3, 6 12, 24, 48, 72 h, 7 days) 6 32.8%(41/125)
Experiment 2
Sham 0 0%(0/18)
SAH 1 30.8%(8/26)
SAH + Vec 2 33.3%(9/27)
SAH + over-Nix 1 28%(7/25)
SAH + Ctr siRNA 1 35.7%(10/28)
SAH + Nix siRNA 2 40%(12/30)